Vaxart Inc (VXRT)

[finesand]

Conclusion - Why the dump and no recovery?

At least one holder sold out or a few reduced their stake
and they are probably continuing until their goals has been reached. Maybe done or not.

They might have found risk is too high after AVIR's legacy drug failed (3 of 3 failed, what a record) and they might think that this weekend's Noro Phase-1 of 2017 related posted will not satisfy the market.

From the abstract: http://www.abstractsonline.com/pp8/#!/4623/presentation/9139

Results: Significant cross-reactivity to GI.3 and GI.4 VLPs was observed in human serum samples vaccinated with GI.1, with negligible cross-reactivity to GII.4....
Conclusions: Although vaccination with the Norwalk strain did not result in significant cross-reactivity against the GII.4 genotype, a higher degree of heterologous cross-reactivity for animals vaccinated against the GII.4 genotype was observed. ....

The genotype GII.4 seems to be key here and only for animals some or even significant reactivity has been observed. Since company's goals is to sell these vaccines to humans and not animals, the result and conclusion might have people disappointed a lot. Hence the exits.

What is the ultimate truth, I can't tell here. Just watching.
If above has merits, sellers had continued today keeping the SP flat. Tomorrow shorts will be back into the game.
GLTU